Syapse works with health systems to implement precision medicine programs across their organizations, enabling oncologists to deliver personalized care to every patient who needs it. The company's end-to-end offering integrates previously fragmented clinical, molecular, treatment, and health outcomes data and delivers it to physicians at the point of care so they can make the most informed decisions. To that end, it can access patient data siloed in EHRs, data warehouses, registries, and other systems. Syapse's flagship product, Syapse Oncology, enables healthcare providers to deliver consistent, cost-effective, patient-centered cancer care. The solution can:
- Empower health systems to deliver consistent, high-quality precision cancer care by standardizing data, clinical workflows, and best practices.
- Remove barriers that prevent oncologists from procuring targeted therapies.
- Enable health systems to take a leading role in moving precision oncology forward.
Select investors Ascension Ventures, Safeguard Scientifics, Social Capital, GE Ventures, Roche Venture Fund, Amgen Ventures, Intermountain Healthcare Innovation Fund, Merck Global Health Innovation Fund
Last update: April 1, 2018
Disclaimer: We can not guarantee that the information on this page is 100% correct. more